Search Results - "Gentles, Lucy"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors by Mukhopadhyay, Asima, Drew, Yvette, Matheson, Elizabeth, Salehan, Mo, Gentles, Lucy, Pachter, Jonathan A., Curtin, Nicola J.

    Published in Biochemical pharmacology (01-09-2019)
    “…[Display omitted] PARP inhibitors (PARPi) represent a major advance in the treatment of ovarian cancer associated with defects in homologous recombination DNA…”
    Get full text
    Journal Article
  3. 3

    Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer by Sharma Saha, Sweta, Gentles, Lucy, Bradbury, Alice, Brecht, Dominik, Robinson, Rebecca, O'Donnell, Rachel, Curtin, Nicola J, Drew, Yvette

    Published in Cancers (20-03-2021)
    “…Defective DNA damage response (DDR) pathways are enabling characteristics of cancers that not only can be exploited to specifically target cancer cells but…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types by Gentles, Lucy, Goranov, Bojidar, Matheson, Elizabeth, Herriott, Ashleigh, Kaufmann, Angelika, Hall, Sally, Mukhopadhyay, Asima, Drew, Yvette, Curtin, Nicola J, O'Donnell, Rachel L

    Published in Cancers (13-03-2019)
    “…Dysfunctional homologous recombination DNA repair (HRR), frequently due to BRCA mutations, is a determinant of sensitivity to platinum chemotherapy and…”
    Get full text
    Journal Article